Final Evidence Report and Meeting Summary
New England CEPAC

PDF cover

Psoriasis: Final Evidence Report and Meeting Summary

ICER’s final report reviewing the comparative clinical effectiveness and value of targeted immunomodulators for treatment of moderate to severe plaque psoriasis. The report includes a summary of voting and policy implications from a November 2016 meeting of the New England CEPAC in Boston, MA.

View

View All Materials on this Topic or Go Back to View More Materials